While the majority of somatic mutations in NOTCH1 in T-ALL are activating and result in aberrant continued signaling [21], a tumor suppressor role of the Notch pathway has been shown in acute myeloid leukemia (AML) [22, 23]. The gene discussed is NOTCH1; the disease is acute myeloid leukemia.